Predictions
BELLUS Health Inc.
Start price
Target price
Perf. (%)
€2.80
04.01.20
04.01.20
-
04.11.21
04.11.21
112.50%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Delivery Hero SE
Start price
Target price
Perf. (%)
€70.22
04.01.20
04.01.20
€150.00
04.11.21
04.11.21
87.27%
06.09.21
06.09.21
Could be worthwhile Investment >10% per year
Nemetschek SE
Start price
Target price
Perf. (%)
€61.45
04.01.20
04.01.20
€61.00
04.11.21
04.11.21
77.87%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
CA Immobilien Anlagen AG
Start price
Target price
Perf. (%)
€37.85
03.01.20
03.01.20
€45.00
04.11.21
04.11.21
-5.81%
28.05.21
28.05.21
Could be worthwhile Investment >10% per year
Small cyclical dependencies
Known brand
Beyond Meat Inc
Start price
Target price
Perf. (%)
€67.31
31.12.19
31.12.19
€85.00
11.01.20
11.01.20
33.71%
11.01.20
11.01.20
Revenue growth >5% per year expected
Alteryx Inc
Start price
Target price
Perf. (%)
€92.42
30.12.19
30.12.19
€75.00
04.11.21
04.11.21
-24.06%
05.11.21
05.11.21
Stable Large shareholder and/or long term investor
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Risky balance sheet
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€83.00
22.12.19
22.12.19
€79.00
04.11.21
04.11.21
-3.61%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Canopy Growth Corp
Start price
Target price
Perf. (%)
€18.00
21.12.19
21.12.19
€30.00
04.11.21
04.11.21
-36.06%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
Future proof or reliable business model
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€59.38
20.12.19
20.12.19
€86.00
23.04.20
23.04.20
21.40%
23.04.20
23.04.20
Fedex Corp.
Start price
Target price
Perf. (%)
€136.70
18.12.19
18.12.19
€150.00
18.12.19
18.12.19
-3.16%
18.12.19
18.12.19
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Adamas Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€3.46
17.12.19
17.12.19
€6.00
04.11.21
04.11.21
103.76%
05.11.21
05.11.21
Nokia Corp.
Start price
Target price
Perf. (%)
€3.24
16.12.19
16.12.19
€4.00
28.01.20
28.01.20
10.68%
28.01.20
28.01.20
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
High dividend yield expected
Enochian Biosciences Inc
Start price
Target price
Perf. (%)
€5.65
11.12.19
11.12.19
€0.000
04.11.21
04.11.21
-2.65%
26.08.21
26.08.21
TeamViewer AG
Start price
Target price
Perf. (%)
€28.94
11.12.19
11.12.19
€20.00
04.11.21
04.11.21
-56.03%
01.11.21
01.11.21
EBIT growth >5% per year expected
Normal challenges to pay loans and raise capital
ROE lower than 10% per year
Below average Management
Inditex S.A.
Start price
Target price
Perf. (%)
€29.74
11.12.19
11.12.19
€35.00
31.01.20
31.01.20
1.48%
31.01.20
31.01.20
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Sustainability is important
Delta Air Lines Inc.
Start price
Target price
Perf. (%)
€49.87
11.12.19
11.12.19
€80.00
27.02.20
27.02.20
-10.17%
27.02.20
27.02.20
Larimar Therapeutics Inc.
Start price
Target price
Perf. (%)
€8.94
10.12.19
10.12.19
€13.00
04.11.21
04.11.21
20.81%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year